Beleagured x-ray digitization firm Fidelity Medical of Florham Park, NJ, announced that it hasfiled its Form 10-K with the Securities and Exchange Commissionstating its 1994 results. Fidelity had postponed filing the formdue to doubts about the company's
Beleagured x-ray digitization firm Fidelity Medical of Florham Park, NJ, announced that it hasfiled its Form 10-K with the Securities and Exchange Commissionstating its 1994 results. Fidelity had postponed filing the formdue to doubts about the company's future (SCAN 2/1/95). Fidelity'sresults closely matched expectations, with annual net revenuesof $3.5 million and a net loss of $1.9 million. Fidelity saidit is exploring options to sustain continued operations and isnegotiating with an investment bank for a private stock placement.It is also examining a potential acquisition.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.